학술논문

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial
Document Type
Article
Source
In: Haematologica. (Haematologica, September 2022, 107(9):2108-2120)
Subject
Language
English
ISSN
15928721
03906078